Pune, India, Novemba 30, 2021 (GLOBE NEWSWIRE) - Imakethe yomhlaba wonke ye-dermal filler kulindeleke ukuthi ifinyelele kumadola ayizigidi eziyizinkulungwane ezingama-6.28 ngo-2028, futhi ngasikhathi sinye, izinga lokukhula lonyaka elihlanganisiwe ukusuka ku-2021 kuya ku-2028 lizofinyelela ku-10.8%.Abantu bahlabeke umxhwele. Esihlokweni sayo esithi “dermal filler market 2021-2028″, “Fortune Business Insights” iveze ukuthi usayizi wemakethe ngo-2020 uzoba ngamadola ayizigidi eziyizinkulungwane ezingama-2.84.
Ukutshalwa kwezimali okukhulayo emnyangweni we-R&D embonini yezimonyo zezokwelapha kulindeleke ukuthi kuqhubekisele phambili ukukhula kwemakethe yokugcwalisa i-dermal. Ngaphezu kwalokho, ukukhuphuka kwemikhuba kanye nokusabalala kokwelashwa kwe-filler kukhule kakhulu ngokuhamba kweminyaka. Isibonelo, embikweni ka-2019 ka-2019 i-International Society of Aesthetic Plastic Surgery (ISAPS), izilinganiso zokuhlinzwa eziyi-4,315,859 ezibandakanya izigcwalisi ze-hyaluronic acid zenziwa emhlabeni wonke ngo-2019. Lesi sibalo sikhuphuke ngo-15.7% ngonyaka ka-2018.
Cela ikhophi yesampula yombiko wocwaningo: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dermal-fillers-market-100939
Umthelela we-COVID-19 usobala emkhakheni wezokunakekelwa kwempilo ngoba iphakathi kwale nselelo engakaze ibonwe yobhubhane lomhlaba wonke. Imboni yezimonyo zezokwelapha ithinteke kakhulu ngoba iyisevisi engabalulekile futhi ozikhethela yona. Ngenxa yokuvinjwa, imboni ibone ukuphazamiseka kwe-supply chain ngenxa yemikhawulo yokungenisa nokuthekelisa, ukuvalwa kwezindiza, ukunciphisa ukukhiqizwa, kanye neziteshi zokunikezela eziphazamisekile.Isibonelo, imali engenayo ye-JUVEDERM Collection ye-ALLERGAN (AbbVie, Inc.), umdlali onamandla emakethe yomhlaba, yehle ngo-42.3% uma kuqhathaniswa nonyaka wezimali ka-2019 (FY). Nokho, imakethe kulindeleke ukuthi ichume futhi phakathi nesikhathi sokubikezela.
Ngokwezinto zokwakha, imakethe ihlukaniswe nge-hyaluronic acid, i-calcium hydroxyapatite, i-poly-l-lactic acid, i-PMMA (i-poly(i-methyl methacrylate)), izigcwalisi ezinamafutha, njll. i-biodegradable.Ngokwesicelo sayo, imakethe ihlukaniswe yaba ukwelashwa kwezibazi, ukwelashwa kokulungiswa kwemibimbi, ukukhulisa izindebe, nokubuyisela ukugcwala.Kubasebenzisi bokugcina, ihlukaniswe yaba imitholampilo yochwepheshe kanye ne-dermatological, izibhedlela nemitholampilo, njll.
Ngokwalo mkhuba, ingxenye yemakethe yengxenye ye-hyaluronic acid iphezulu kakhulu ngo-2020, ngama-77.1%.Lokhu kungenxa yokwanda kwesidingo semikhiqizo ye-hyaluronic acid ngenxa yokuphepha kwayo nempilo ende.Ngaphezu kwalokho, izinkampani eziningi zihlinzeka nge-hyaluronic acid. imikhiqizo emazweni anomnotho ozinzile futhi okhule kakhulu njenge-Europe.Kulesi sifunda, i-AbbVie, Inc. kulindeleke ukuthi ikhuthaze ukukhula kwalesi sigaba ngesikhathi sokubikezela.
Umbiko Wocwaningo Lwemakethe Ye-Quick Buy-Dermal Filler: https://www.fortunebusinessinsights.com/checkout-page/100939
Ngenxa yeholo eliphezulu elilahlwayo labantu bakulesi sifunda, iNyakatho Melika kulindeleke ukuthi igcine isikhundla sayo sokuhola futhi ithathe isikhundla esiphezulu emakethe ngesikhathi sokubikezela. Ngaphezu kwalokho, kulindeleke ukuthi imithetho nemithethonqubo eqinile ehlobene nemikhiqizo emisha khuthaza ukuthuthukiswa kwemakethe yesifunda.Ngokwesibonelo, ngokusho kwedatha evela ku-American Society of Plastic Surgeons (ASPS), ngo-2019, cishe izigidi eziyi-16.3 izinqubo ezihlasela kancane zenziwa e-United States, kanti usayizi wemakethe ngo-2020 wawuse-US. $1.22 billion.
Isifunda sase-Asia-Pacific kulindeleke ukuthi sibonise ingxenye enkulu yemakethe yezinsizakalo zokubamba. Lokhu kungenxa yokwanda kokuqwashisa kwabantu mayelana nokubukeka kwabo endaweni. Isibonelo, ngoJulayi 2020, i-LG Chem yaseNingizimu Korea yamemezela ukuthi yethule i- uvivinyo lomtholampilo lwe-dermal filler yekhwalithi ephezulu ebizwa nge-YVOIRE Y-Solution e-China.Ngakho-ke, ukwethulwa kwayo kulindeleke ukuthi kukhuphule imakethe yesifunda ngesikhathi sokubikezela.
unokungabaza okuthile?Xhumana nochwepheshe bethu: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/dermal-fillers-market-100939
Izinkampani ezinkulu zilwela ukugcina isikhundla sazo ngokugxila ekukhishweni kwemikhiqizo emisha, ngaleyo ndlela ziqinise imakethe.Isibonelo, ngo-Agasti 2020, i-Revance Therapeutics, Inc. yethule i-RHA Dermal Filler Line. Iwukugcwalisa kuqala futhi ukuphela kwe-dermal filler egunyazwe i-FDA yokulungisa imibimbi yobuso nemibimbi e-United States.Lelisu elinolaka kulindeleke ukuthi liqhubekisele phambili imakethe eminyakeni embalwa ezayo.
Thola umbiko wakho wocwaningo owenziwe ngezifiso: https://www.fortunebusinessinsights.com/enquiry/customization/dermal-fillers-market-100939
I-Fortune Business Insights™ ihlinzeka ngokuhlaziywa kwebhizinisi okuphrofeshinali kanye nedatha enembile ukusiza izinhlangano zabo bonke osayizi zenze izinqumo ngesikhathi.Sithungela amakhasimende ethu izixazululo ezintsha ukuze siwasize abhekane nezinselele ezihlukile ezibhekene nebhizinisi lawo.Umgomo wethu uwukunikeza amakhasimende ethu imakethe ephelele. ubuhlakani kanye nokubukezwa okuningiliziwe kwezimakethe abasebenza kuzo.
Umbiko wethu uqukethe inhlanganisela eyingqayizivele yemininingwane ebonakalayo kanye nokuhlaziywa kwekhwalithi ukusiza izinkampani zifinyelele ukukhula okusimeme.Ithimba lethu labahlaziyi abanolwazi nabeluleki lisebenzisa amathuluzi namasu okucwaninga ahamba phambili embonini ukuze ahlanganise ucwaningo lwemakethe olubanzi, oluhlanganiswe nedatha efanele.
Kwa-Fortune Business Insights™, umgomo wethu uwukugqamisa amathuba okukhula anenzuzo kakhulu kumakhasimende ethu.Ngakho-ke, sinikeza iziphakamiso ukuze sikwazi ukuphendula kalula ezinguqukweni zobuchwepheshe kanye nemakethe.Izinsizakalo zethu zokubonisana ziklanyelwe ukusiza izinhlangano ukuthi zibone okufihliwe. amathuba futhi baqonde izinselele zamanje zokuncintisana.
I-Fortune Business Insight™ Pvt.Ltd.308, Ubuholi obuphakeme, Survey No. 36, Baner, Pune-Bangalore Highway, Pune-411045, Maharashtra, India.
Phone: United States: +1 424 253 0390 UK: +44 2071 939123 APAC: +91 744 740 1245 Email: sales@fortunebusinessinsights.comFortune Business Insights™ LinkedIn | Twitter | Blog
Isikhathi sokuthumela: Dec-24-2021